4//SEC Filing
GALEN PARTNERS IV LP 4
Accession 0001209191-10-018428
CIK 0001254419other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:06 PM ET
Size
24.6 KB
Accession
0001209191-10-018428
Insider Transaction Report
Form 4
MEDASSETS INCMDAS
Transactions
- Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN) - Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN)
CLAUDIUS LLC
10% Owner
Transactions
- Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN) - Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN) - Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN) - Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN) - Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN)
GALEN PARTNERS IV LP
Other
Transactions
- Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN) - Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN)
Transactions
- Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN) - Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN) - Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN)
Claudius IV, LLC
Other
Transactions
- Sale
Common Stock
2010-03-23$22.06/sh−100$2,206→ 5,817,199 total(indirect: See FN) - Sale
Common Stock
2010-03-22$22.13/sh−40,273$891,169→ 5,817,299 total(indirect: See FN) - Sale
Common Stock
2010-03-19$22.12/sh−2,000$44,240→ 5,857,572 total(indirect: See FN)
Footnotes (9)
- [F1]The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Funds on September 1, 2009
- [F2]The shares were sold as follows: 352 shares by Galen Partners IV, L.P. ("Galen IV"), 28 shares by Galen Partners International IV, L.P. ("Galen International IV"), 1 share by Galen Employee Fund IV, L.P. ("Employee Fund IV"), 1,480 shares by Galen Partners III, L.P. ("Galen III"), 134 shares by Galen Partners International III, L.P. ("Galen International III") and 5 shares by Galen Employee Fund III, L.P. ("Employee Fund III" and, collectively with Galen IV, Galen International IV, Employee Fund IV, Galen III, Galen International III, the "Funds").
- [F3]The shares are held as follows: 1,029,717 by Galen IV, 81,797 by Galen International IV, 1,435 by Employee Fund IV, 4,333,349 by Galen III, 392,717 by Galen International III and 18,557 by Employee Fund III. Claudius IV, L.L.C. ("Cladius IV") serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F4]Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
- [F5]The shares were sold as follows: 7,084 shares by Galen IV, 563 shares by Galen International IV, 10 shares by Employee Fund IV, 29,811 shares by Galen III, 2,702 shares by Galen International III and 103 shares by Employee Fund III.
- [F6]The shares were sold at prices between $22.06 and $22.37. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F7]The shares are held as follows: 1,022,633 by Galen IV, 81,234 by Galen International IV, 1,425 by Employee Fund IV, 4,303,538 by Galen III, 390,015 by Galen International III and 18,454 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
- [F8]The shares were sold as follows: 18 shares by Galen IV, 1 share by Galen International IV, 74 shares by Galen III and 7 shares by Galen International III.
- [F9]The shares are held as follows: 1,022,615 by Galen IV, 81,233 by Galen International IV, 1,425 by Employee Fund IV, 4,303,464 by Galen III, 390,008 by Galen International III and 18,454 by Employee Fund III. Claudius IV serves as the sole General Partner of Galen IV and Galen International IV and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Wesson Enterprises, Inc. serves as the sole General Partner of Employee Fund IV and Employee Fund III and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds.
Documents
Issuer
MEDASSETS INC
CIK 0001254419
Entity typeother
Related Parties
1- filerCIK 0001203341
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:06 PM ET
- Size
- 24.6 KB